The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
Open accessAbstract
Spatial and temporal dissection of the genomic changes occurring during the evolution of human non–small cell lung cancer (NSCLC) may help elucidate the basis for its dismal prognosis. We sequenced 25 spatially distinct regions from seven operable NSCLCs and found evidence of branched evolution, with driver mutations arising before and after subclonal diversification. There was pronounced intratumor heterogeneity in copy number alterations, translocations, and mutations associated with APOBEC cytidine deaminase activity. Despite maintained carcinogen exposure, tumors from smokers showed a relative decrease in smoking-related mutations over time, accompanied by an increase in APOBEC-associated mutations. In tumors from former smokers, genome-doubling occurred within a smoking-signature context before subclonal diversification, which suggested that a long period of tumor latency had preceded clinical detection. The regionally separated driver mutations, coupled with the relentless and heterogeneous nature of the genome instability processes, are likely to confound treatment success in NSCLC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While the full extent to which mutational processes account for unique combinations of somatic genomic alterations in NSCLC is currently unknown, there is evidence that APOBEC-mediated mutagenesis fuels sub-clonal diversification and branched evolution78, 79.”
From Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy (2019) · cites this paper as [79]
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Estimating the Dimension of a Model
Schwarz, G. (1978) · The Annals of Statistics · doi:10.1214/aos/1176344136 · Cited by 47,033
Tamura, K., Peterson, D., Peterson, N., Stecher, G., Nei, M., & Kumar, S. (2011) · Molecular Biology and Evolution · doi:10.1093/molbev/msr121 · Cited by 40,207
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,724
Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
Circos: An information aesthetic for comparative genomicsPreprint
Krzywinski, M. I., Schein, J. E., Birol, İ., Connors, J. M., Gascoyne, R. D., Horsman, D. E., Jones, S. J. M., & Marra, M. A. (2009) · Genome Research · doi:10.1101/gr.092759.109 · Cited by 11,073
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Self-citation<tt>BLAT</tt> —The <tt>BLAST</tt> -Like Alignment Tool
Kent, W. J. (2002) · Genome Research · doi:10.1101/gr.229202 · Cited by 8,480
Research works printed but not linked: 1
- Soria J. C., Cruz C., Bahleda R., Delord J. P., Horn L., Herbst R. S., Spigel D., Mokatrin A., Fine G., Gettinger S., Clinical activity, safety and biomarkers of PD-L1 blockade in non-small cell lung cancer (NSCLC). Eur. J. Cancer 49 (suppl. 2), 3408 (2013).
Cited by
Sorted by citations
Items 701–800 of 1,000
Clinical Implications of Noncoding Indels in the Surfactant-Encoding Genes in Lung Cancer
Nakagomi, T., Hirotsu, Y., Goto, T., Shikata, D., Yokoyama, Y., Higuchi, R., Ohtake, S., Amemiya, K., Oyama, T., Mochizuki, H., et al. (2018) · Cancers · doi:10.2139/ssrn.3279166 · Cited by 11
Urinary Biomarkers for Early Diagnosis of Lung Cancer
Gasparri, R., Sedda, G., Caminiti, V., Maisonneuve, P., Prisciandaro, E., & Spaggiari, L. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081723 · Cited by 11
Furness, A. J. S., Quezada, S. A., & Peggs, K. S. (2016) · Immunotherapy · doi:10.2217/imt-2016-0064 · Cited by 11
Nishikawa, S., Kimura, H., Koba, H., Yoneda, T., Watanabe, S., Sakai, T., Hara, J., Sone, T., Kasahara, K., & Nakao, S. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.01.144 · Cited by 10
Lorber, T., Andor, N., Dietsche, T., Perrina, V., Juškevičius, D., Pereira, K., Greer, S., Krause, A., Müller, D. C., Prince, S. S., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5183 · Cited by 11
Targeting cytokinesis bridge proteins to kill high-CIN type tumors
Xie, B., Liang, X., Yue, W., Ma, J., Li, X., Zhang, N., Wang, P., Liu, C., Shi, X., Qiao, J., et al. (2021) · Fundamental Research · doi:10.1016/j.fmre.2021.08.015 · Cited by 10
Lin, M., Sade-Feldman, M., Wirth, L. J., Lawrence, M. S., & Faden, D. L. (2022) · npj Precision Oncology · doi:10.1038/s41698-022-00314-3 · Cited by 11
Lahtela, J., Pradhan, B., Närhi, K. M., Hemmes, A., Särkioja, M., Kovanen, P. E., Brown, A. M., & Verschuren, E. W. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.019257 · Cited by 12
Lu, D. M., Graf, R. P., Harvey, M., Madan, R. A., Heery, C. R., Marté, J. L., Beasley, S., Tsang, K. Y., Krupa, R., Louw, J. E., et al. (2015) · Journal of Circulating Biomarkers · doi:10.5772/60745 · Cited by 11
Cancer Evo-Dev, a novel hypothesis derived from studies on hepatitis B virus-induced carcinogenesis
Cao, G. (2017) · Hepatoma Research · doi:10.20517/2394-5079.2017.45 · Cited by 11
MicroRNAs and Drug Resistance in Non-Small Cell Lung Cancer: Where Are We Now and Where Are We Going
Cuttano, R., Afanga, M. K., & Bianchi, F. (2022) · Cancers · doi:10.3390/cancers14235731 · Cited by 12
Molecular clonality analysis of esophageal adenocarcinoma by multiregion sequencing of tumor samples
van Nistelrooij, A. M. J., van Marion, R., Koppert, L. B., Biermann, K., Spaander, M. C. W., Tilanus, H. W., van Lanschot, J. J. B., Wijnhoven, B. P. L., & Dinjens, W. N. M. (2017) · BMC Research Notes · doi:10.1186/s13104-017-2456-5 · Cited by 10
Liao, Y., Ma, Z., Zhang, Y., Li, D., Lv, D., Chen, Z., Li, P., AI-Dherasi, A. M., Zheng, F., Tian, J., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2458 · Cited by 10
Distinguishing multiple lung primaries from intra-pulmonary metastases and treatment implications
Voulaz, E., Novellis, P., Rossetti, F. R., Solinas, M., Rossi, S., Alloisio, M., Pelosi, G., & Veronesi, G. (2020) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2020.1823223 · Cited by 10
Cuttano, R., Colangelo, T., Guarize, J., Dama, E., Cocomazzi, M. P., Mazzarelli, F., Melocchi, V., Palumbo, O., Marino, E., Belloni, E., et al. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01394-1 · Cited by 12
Kammer, M. N., Mori, H., Rowe, D. J., Chen, S., Vasiukov, G., Atwater, T., Senosain, M.-F., Antic, S., Zou, Y., Chen, H., et al. (2023) · JTO Clinical and Research Reports · doi:10.1016/j.jtocrr.2023.100504 · Cited by 11
Self-citationMatsuda, I., Kan, K., Doi, S., Motoki, Y., Onodera, M., & Hirota, S. (2015) · PubMed Central · Cited by 10
A Direct Test of Selection in Cell Populations Using the Diversity in Gene Expression within Tumors
Li, C., Hou, Y., Xu, J., Zhang, A., Liu, Z., Qi, F., Yang, Z., Chen, K., Liu, S., Huang, H., et al. (2017) · Molecular Biology and Evolution · doi:10.1093/molbev/msx115 · Cited by 8
Kikutake, C., Yoshihara, M., Sato, T., Saito, D., & Suyama, M. (2018) · Oncotarget · doi:10.18632/oncotarget.26485 · Cited by 10
Spatial UBE2N protein expression indicates genomic instability in colorectal cancers
Gemoll, T., Miroll, E., Klein, O., Lischka, A., Eravci, M., Thorns, C., & Habermann, J. K. (2019) · BMC Cancer · doi:10.1186/s12885-019-5856-1 · Cited by 10
Chen, W., Liu, W., Li, Y., Wang, J., Ren, Y., Wang, G., Chen, C., & Li, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.716042 · Cited by 10
Mansour, H., Ouhajjou, A., Bajić, V. B., & Incitti, R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01215 · Cited by 10
Blagosklonny, M. V. (2024) · Oncoscience · doi:10.18632/oncoscience.593 · Cited by 9
Zheng, Y., Yang, W. C., Wu, W., Jin, F., Lu, D., Gao, J., & Wang, S. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.101926 · Cited by 11
Decoding temporal heterogeneity in NSCLC through machine learning and prognostic model construction
Cheng, J., Xiao, M., Meng, Q., Zhang, M., Zhang, D., Liu, L., Jin, Q., Fu, Z., Li, Y., Chen, X., et al. (2024) · World Journal of Surgical Oncology · doi:10.1186/s12957-024-03435-0 · Cited by 10
Innovative approaches for lung cancer screening and interception
Zhang, J., Park, M. S., Pandya, T., Shum, E., Wu, J., Heeke, S., Salehi‐Rad, R., Marron, T. U., Wei, Z., Li, H., et al. (2026) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-026-01131-4 · Cited by 12
Self-citationExosomal lncCRLA is predictive for the evolvement and development of lung adenocarcinoma
Lin, S., He, C., Song, L., Sun, L., Zhao, R., Min, W., & Zhao, Y. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216588 · Cited by 10
Chang, E., & An, J. (2024) · BMB Reports · doi:10.5483/bmbrep.2023-0244 · Cited by 8
Maru, Y., Kohno, M., Suzuka, K., Odaka, A., Masuda, M., Araki, A., Itami, M., Tanaka, N., & Hippo, Y. (2024) · Human Cell · doi:10.1007/s13577-024-01048-z · Cited by 9
Lopez, J. S., Harris, S., Roda, D., & Yap, T. A. (2015) · Translational Oncogenomics · doi:10.4137/tog.s30533 · Cited by 9
The promise of multiparametric imaging in oncology: how do we move forward?
Even, A. J. G., Ruysscher, D. D., & van Elmpt, W. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3361-1 · Cited by 9
Lapère, C., Cortot, A. B., Grégoire, V., Cockenpot, V., Tulasne, D., & Copin, M. (2017) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000810 · Cited by 9
Dong, L., Xia, J., Zhang, J., Zhang, Y., Zhu, N., Zhang, P., Zhang, Y., Zhang, X., & Li, S. (2018) · BMC Pulmonary Medicine · doi:10.1186/s12890-018-0585-9 · Cited by 9
Molecular subtyping of bladder cancer
Smelser, W., Woolbright, B. L., & Taylor, J. A. (2019) · Current Opinion in Urology · doi:10.1097/mou.0000000000000599 · Cited by 9
A Pathway-Based Strategy to Identify Biomarkers for Lung Cancer Diagnosis and Prognosis
Sheng, M., Xie, X., Wang, J., & Gu, W. (2019) · Evolutionary Bioinformatics · doi:10.1177/1176934319838494 · Cited by 9
Mutation-Derived Long Noncoding RNA Signature Predicts Survival in Lung Adenocarcinoma
Yang, L., Guo, G., Yu, X., Wen, Y., Lin, Y., Zhang, R., Zhao, D., Huang, Z., Wang, G., Yan, Y., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.780631 · Cited by 9
Karen‐Ng, L. P., Ahmad, U. S., Gomes, L., Hunter, K. D., Wan, H., Hagi‐Pavli, E., & Parkinson, E. K. (2022) · Cancers · doi:10.3390/cancers14112636 · Cited by 8
Palmieri, M., & Frullanti, E. (2023) · Medical Sciences · doi:10.3390/medsci11010008 · Cited by 9
Adapting the drivers to the road: a new strategy for cancer evolution?
Touat, M., Dhermain, F. G., André, F., & Sanson, M. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv137 · Cited by 11
Piñeiro-Yáñez, E., Jiménez‐Santos, M. J., Goméz-López, G., & Al‐Shahrour, F. (2019) · Cancers · doi:10.3390/cancers11091361 · Cited by 8
Cassidy, J. W., & Bruna, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804010-2.00004-7 · Cited by 9
Birkbak, N. J., Hiley, C. T., & Swanton, C. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.2976 · Cited by 9
Self-citationTissue structure accelerates evolution: premalignant sweeps precede neutral expansionPreprint
West, J., Schenck, R. O., Gatenbee, C., Robertson‐Tessi, M., & Anderson, A. R. A. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/542019 · Cited by 9
Liu, Y., Yang, M., Deng, Y., Su, G., Enninful, A., Guo, C. C., Tebaldi, T., Zhang, D., Kim, D., Bai, Z., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.01.232496 · Cited by 10
Sitthirak, S., Wangwiwatsin, A., Jusakul, A., Namwat, N., Klanrit, P., Dokduang, H., Sa-Ngiamwibool, P., Titapun, A., Jareanrat, A., Thanasukarn, V., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-95142-3 · Cited by 8
Schwartz, I., Budroni, V., Meyenberg, M., Hodáková, Z., Hornegger, H., Hacker, K., Schwartz, S., Grabarczyk, D. B., Ehrmann, J. F., Scinicariello, S., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68420-5 · Cited by 8
Extrinsic cell death pathway plasticity: a driver of clonal evolution in cancer?
Seidel, E., & von Karstedt, S. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01251-7 · Cited by 9
Results from an IFCC global survey on laboratory practices for the analysis of circulating tumor DNA
Linder, M. W., Huggett, J. F., Baluchova, K., Capoluongo, E., Payne, D. A., Salinas, A. V., Haselmann, V., Ashavaid, T. F., Pan, S., & Ahmad‐Nejad, P. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117398 · Cited by 8
Huang, C., Jiang, N., Shen, M., Lai, G. G. Y., Tan, A. C., Jain, A., Saw, S. P. L., Ang, M., Ng, Q. S., Lim, W., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-2551 · Cited by 8
Lai, J., Lai, Y.-C., Chen, Y. C., Wang, N.-K., Pan, J.-N., Wang, W.-S., & Chang, S.-C. (2017) · Cancer Gene Therapy · doi:10.1038/cgt.2017.26 · Cited by 9
High MYC Levels Favour Multifocal Carcinogenesis
Sollazzo, M., Genchi, C., Paglia, S., Giacomo, S. D., Pession, A., de Biase, D., & Grifoni, D. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00612 · Cited by 8
Prediction of early breast cancer patient survival using ensembles of hypoxia signatures
Gong, I. Y., Fox, N. S., Huang, V., & Boutros, P. C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204123 · Cited by 8
Rodriguez, E. F., Tseng, L., Marchi, F. D., Haung, J., Belchis, D., Xian, R. R., Gocke, C. D., Eshleman, J. R., Illei, P. B., & Lin, M. (2020) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-020-00471-w · Cited by 9
Openshaw, M. R., & McVeigh, T. P. (2020) · Frontiers in Digital Health · doi:10.3389/fdgth.2020.573010 · Cited by 9
Martin-Fernandez, M. L. (2022) · Cancers · doi:10.3390/cancers14030686 · Cited by 8
Monitoring Circulating Tumor DNA in Untreated Non-Small-Cell Lung Cancer Patients
Ryu, W. K., Oh, S., Lim, J. H., Lee, S. J., Shin, H., & Ryu, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179527 · Cited by 8
Self-citationZhong, W., Su, J., Xu, F., Zhai, H.-R., Zhang, X., Yang, X., Chen, Z., Chen, Z., Li, W., Dong, S., et al. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.09.007 · Cited by 8
The genomic dynamics during progression of lung adenocarcinomas
Yang, B., Luo, L., Luo, W., Zhou, Y., Yang, C., Xiong, T., Li, X., Meng, X., Li, L., Zhang, X., et al. (2017) · Journal of Human Genetics · doi:10.1038/jhg.2017.40 · Cited by 8
Comparison of Burnet's clonal selection theory with tumor cell-clone development
Arneth, B. M. (2018) · Theranostics · doi:10.7150/thno.24083 · Cited by 10
Rachiglio, A. M., Sacco, A., Forgione, L., Esposito, C., Chicchinelli, N., & Normanno, N. (2020) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2020.00004 · Cited by 9
Genomic assessment distinguishes intrapulmonary metastases from synchronous primary lung cancers
Corsini, E. M., Wang, J., Wu, C.-C., Fujimoto, J., Negrao, M. V., Chen, R., Quek, K., Mitchell, K. G., Chow, C.-W. B., Little, L., et al. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd-20-1 · Cited by 8
Jhanwar, S. C., Xu, X. L., Elahi, A. H., & Abramson, D. H. (2020) · Advances in Biological Regulation · doi:10.1016/j.jbior.2020.100723 · Cited by 8
Cooperation among Tumor Cell Subpopulations Leads to Intratumor Heterogeneity
Li, X., & Thirumalai, D. (2020) · Biophysical Reviews and Letters · doi:10.1142/s1793048020300042 · Cited by 7
Wang, Z., Zhang, L., He, L., Cui, D., Liu, C., Yin, L., Zhang, M., Jiang, L., Gong, Y., Wang, W., et al. (2020) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2020.03.05 · Cited by 8
Reply: Is the evolution of tumors Darwinian or non-Darwinian?
Williams, M. J., Werner, B., Barnes, C. P., Graham, T. A., & Sottoriva, A. (2018) · National Science Review · doi:10.1093/nsr/nwx131 · Cited by 8
Human APOBEC3B promotes tumor heterogeneity in vivo including signature mutations and metastasesPreprint
Durfee, C. C., Temiz, N. A., Levin-Klein, R., Argyris, P. P., Alsøe, L., Carracedo, S., de la Vega, A. A., Proehl, J., Holzhauer, A. M., Seeman, Z. J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.24.529970 · Cited by 8
Bica, C., Zănoagă, O., Pop, L., Ciocan, C. A., Ráduly, L., Nutu, A. M., Berindan‐Neagoe, I., & Bender, A. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1693784 · Cited by 8
Genomic landscape of ground glass opacities (GGOs) in East Asians
Cao, P., Hu, S., Kong, K., Han, P., Yue, J., Deng, Y. L., Zhao, B., & Li, F. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-21-82 · Cited by 7
Li, H., Zhu, B., Jiang, X., Guo, L., Xie, Y., Xu, L., & Li, Q. (2024) · Biometrics · doi:10.1093/biomtc/ujae066 · Cited by 7
Tseng, L., Marchi, F. D., Pallavajjalla, A., Rodriguez, E. F., Xian, R. R., Belchis, D., Gocke, C. D., Eshleman, J. R., Illei, P. B., & Lin, M. (2019) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqz077 · Cited by 7
Tabanelli, V., Melle, F., Motta, G., Mazzara, S., Fabbri, M., Corsini, C. A., Gerbino, E., Calleri, A., Sapienza, M. R., Abbene, I., et al. (2020) · Haematologica · doi:10.3324/haematol.2020.249664 · Cited by 7
Park, S., Lee, J.-C., & Choi, C. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112236 · Cited by 7
Ciceri, S., Carenzo, A., Iannò, M. F., Bertolotti, A., Morosi, C., Luksch, R., Spreafico, F., Collini, P., Radice, P., Massimino, M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-20536-6 · Cited by 7
The APOBEC3B cytidine deaminase is an adenovirus restriction factor
Lejeune, N., Mathieu, S., Decloux, A., Poulain, F., Blockx, Z., Raymond, K. A., Willemart, K., Vartanian, J., Suspène, R., & Gillet, N. A. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011156 · Cited by 7
Navone, N. M., & Labanca, E. (2017) · Molecular and translational medicine · doi:10.1007/978-3-319-55825-7_7 · Cited by 7
Pharmacogenomic Considerations in the Treatment of Muscle-Invasive Bladder Cancer
Zuiverloon, T. C. M., & Theodorescu, D. (2017) · Pharmacogenomics · doi:10.2217/pgs-2017-0055 · Cited by 7
Mutational Events in Lung Cancer
Morgensztern, D., Devarakonda, S. H. K., Mitsudomi, T., Maher, C. A., & Govindan, R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-52357-8.00011-1 · Cited by 8
Ma, W., Guo, L., Shan, L., Liu, X., Lyu, N., & Ying, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-11453-0 · Cited by 7
Clonal analysis of early-stage bilateral papillary thyroid cancer identifies field cancerization
Su, X., Chen, S., He, K., Mao, Z., Ruan, J., Zhou, J., Teng, X., Jin, J., Fahey, T. J., Wang, W., et al. (2019) · Endocrine · doi:10.1007/s12020-019-01877-1 · Cited by 7
Self-citationTamiya, M., Tamiya, A., Okamoto, N., Taniguchi, Y., Nishino, K., Atagi, S., Hirashima, T., Imamura, F., Kumagai, T., & Suzuki, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-89006-9 · Cited by 8
Discrimination Between Primary Lung Cancer and Lung Metastases by Genomic Profiling
Higuchi, R., Goto, T., Nakagomi, T., Hirotsu, Y., Oyama, T., Amemiya, K., Mochizuki, H., & Omata, M. (2021) · JTO Clinical and Research Reports · doi:10.1016/j.jtocrr.2021.100255 · Cited by 7
Genomic Landscape of NSCLC in the Republic of Ireland
Keogh, R. J., Barr, M. P., Keogh, A., McMahon, D., O’Brien, C. P., Finn, S. P., & Naidoo, J. (2023) · JTO Clinical and Research Reports · doi:10.1016/j.jtocrr.2023.100627 · Cited by 6
Immune evolution in pre-invasive lung adenocarcinoma
Balasubramanian, A., & Asselin-Labat, M.-L. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.04.005 · Cited by 6
Clonal Evolution: Multiregion Sequencing of Esophageal Adenocarcinoma Before and After Chemotherapy
Devarakonda, S. H. K., & Govindan, R. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0739 · Cited by 6
Shifting patterns of genomic variation in the somatic evolution of papillary thyroid carcinoma
Rubinstein, J. C., Brown, T. C., Christison-Lagay, E. R., Zhang, Y., Kunstman, J. W., Juhlin, C. C., Nelson-Williams, C. J., Goh, G., Quinn, C., Callender, G. G., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2665-7 · Cited by 6
Immune Checkpoint Inhibitors in Lung Cancer – An Unheralded Opportunity?
Marshall, R., Popple, A. L., Kordbacheh, T., Honeychurch, J., Finn, C. F., & Illidge, T. (2017) · Clinical Oncology · doi:10.1016/j.clon.2016.12.003 · Cited by 6
Genomics, Endoscopy, and Control of Gastroesophageal Cancers: A Perspective
Reid, B. J. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.02.005 · Cited by 6
Driving to Cancer on a Four-Lane Expressway
Galluzzi, L., & Vitale, I. (2017) · Trends in Genetics · doi:10.1016/j.tig.2017.06.003 · Cited by 6
Hashimoto, T., Osoegawa, A., Takumi, Y., Abe, M., Kobayashi, R., Miyawaki, M., Takeuchi, H., Okamoto, T., & Sugio, K. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.08.013 · Cited by 6
Prognostic significance of an invasive leader cell–derived mutation cluster on chromosome 16q
Pedro, B. A., Rupji, M., Dwivedi, B., Kowalski, J., Konen, J. M., Owonikoko, T. K., Ramalingam, S. S., Vertino, P. M., & Marcus, A. I. (2020) · Cancer · doi:10.1002/cncr.32903 · Cited by 6
Experimental and bioinformatics considerations in cancer application of single cell genomics
Tan, J. H. J., Kong, S. L., Tai, J. A., Poh, H. M., Yao, F., Sia, Y. Y., Lim, E. K. H., Takano, A. M., Tan, D. S.-W., Javed, A., et al. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.12.021 · Cited by 6
Karen‐Ng, L. P., James, E. L., Stephen, A. S., Bennett, M. H., Mycielska, M. E., & Parkinson, E. K. (2021) · Cancers · doi:10.3390/cancers13164212 · Cited by 6
Kamp, E. J. C. A., Peppelenbosch, M. P., Doukas, M., Verheij, J., Ponsioen, C. Y., van Marion, R., Bruno, M. J., Koerkamp, B. G., Dinjens, W. N. M., & de Vries, A. C. (2021) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000410 · Cited by 6
Drug-Resistant Brain Metastases: A Role for Pharmacology, Tumor Evolution, and Too-Late Therapy
Stricker, T. P., & Arteaga, C. L. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1166 · Cited by 6
Profiling lung adenocarcinoma by liquid biopsy: can one size fit all?
Clifford, H., Cassidy, A. P., Vaughn, C. M., Tsai, E. S., Seres, B., Patel, N., O’Neill, H. L., Hewage, E., & Cassidy, J. W. (2016) · Cancer Nanotechnology · doi:10.1186/s12645-016-0023-8 · Cited by 6
TrackSig: reconstructing evolutionary trajectories of mutations in cancerPreprint
Rubanova, Y., Shi, R., Harrigan, C. F., Li, R., Wintersinger, J., Sahin, N., Deshwar, A., Morris, Q., PCAWG Evolution and Heterogeneity Working Group, & PCAWG network (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/260471 · Cited by 6
Cell-free DNA assay for malignancy classification of high-risk lung nodules
Wang, S., Meng, F., Chen, P., Lv, Y., Wu, M., Tang, H., Bao, H., Wu, X., Shao, Y., Wang, J., et al. (2024) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2024.04.026 · Cited by 5
Dragoumani, K., Kletsas, D., Chrousos, G. P., Vlachakis, D., & Balatsos, N. A. A. (2025) · Genes · doi:10.3390/genes16070796 · Cited by 5
Uusküla-Reimand, L., Lee, C. A., Oh, R. H., Klein, Z. P., Adler, N., Alvi, S. A., Langille, E. R., Pasini, E., Cheng, K. C. L., Serafimova, E., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65005-6 · Cited by 6
Self-citationTemporal and structural patterns of hepatitis B virus integrations in hepatocellular carcinoma
Ren, H., Chen, X., Wang, J., Chen, Y., Hafiz, A., Xiao, Q., Fu, S., Madireddy, A., Li, W. V., Shi, X., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.29187 · Cited by 5
Metadata
- Authors
- de Bruin, E. C., McGranahan, N., Mitter, R., Salm, M., Wedge, D. C., Yates, L., Jamal-Hanjani, M., Shafi, S., Murugaesu, N., Rowan, A. J., Grönroos, E., Muhammad, M. A., Horswell, S., Gerlinger, M., Varela, I., Jones, D., Marshall, J., Voet, T., Van Loo, P., Rassl, D. M., Rintoul, R. C., Janes, S. M., Lee, S.-M., Forster, M., Ahmad, T., Lawrence, D., Falzon, M., Capitanio, A., Harkins, T. T., Lee, C. C., Tom, W., Teefe, E., Chen, S.-C., Begum, S., Rabinowitz, A., Phillimore, B., Spencer-Dene, B., Stamp, G., Szallasi, Z., Matthews, N., Stewart, A., Campbell, P., & Swanton, C.
- Affiliations
- Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6BT, UK.
- Cancer Research UK (GB)
- Wellcome Sanger Institute (GB)
- University of Cambridge (GB)
- Cancer Research UK London Research Institute, London WC2A 3LY, UK.
- Universidad de Cantabria (ES)
- Wellcome Trust Sanger Institute, Hinxton, CB10 1SA, UK.
- Papworth Hospital NHS Foundation Trust (GB)
- University College London (GB)
- Thermo Fisher Scientific (United States) (US)
- Technical University of Denmark, 2800 Kongens Lyngby, Denmark.
- Corresponding author
- McGranahan, Nicholas
- Mitter, Richard
- Salm, Max
- Wedge, David C.
- Yates, Lucy
- Swanton, Charles
- ORCID
- McGranahan, Nicholas
- Mitter, Richard
- Salm, Max
- Wedge, David C.
- Yates, Lucy
- Murugaesu, Nirupa
- Rowan, Andrew J.
- Horswell, Stuart
- Gerlinger, Marco
- Varela, Ignacio
- Jones, David
- Voet, Thierry
- Rassl, Doris M.
- Rintoul, Robert C.
- Janes, Sam M.
- Lee, Siow-Ming
- Forster, Martin
- Lawrence, David
- Falzon, Mary
- Capitanio, Arrigo
- Harkins, Timothy T.
- Lee, Clarence C.
- Teefe, Enock
- Begum, Sharmin
- Rabinowitz, Adam
- Stamp, Gordon
- Matthews, Nik
- Campbell, Peter
- Swanton, Charles
- Venue
- Science
- Published
- 2014-10-10
- Volume
- 346
- Issue
- 6206
- Pages
- 251-256
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2108371618
- Cited by
- 1,117
- References
- 62
- Citations by year
- 2026: 38 · 2025: 43 · 2024: 59 · 2023: 82 · 2022: 82 · 2021: 86 · 2020: 99 · 2019: 113 · 2018: 111 · 2017: 145 · 2016: 131 · 2015: 119 · 2014: 9
- FWCI
- 43.17
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- UCrea (University of Cantabria) (acceptedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- Prostate Cancer Foundation
- Breast Cancer Research Foundation
- Wellcome Trust (091730, 105104, 088340)
- Cancer Research UK (259303, A11590, A4688, A17786, 17001, A19310, 17786, 18377)
- National Institute for Health and Care Research (CL-2011-18-001)
- Academy of Medical Sciences (AMS-SGCL7-Murugaesu)
- University College London
- European Commission (259303)
- Rosetrees Trust (M35-F1-CD1)
- Fonds Wetenschappelijk Onderzoek
- Ministerio de Economía y Competitividad
- Vlaamse regering
- National Institutes of Health
- Medical Research Council
- NIHR Cambridge Biomedical Research Centre
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Treatments and Mutations
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- non-small cell lung cancer, tumor evolution, intratumoral heterogeneity, driver mutations, copy number alterations, chromosomal translocation, APOBEC mutational signature, genome doubling, tumor latency, carcinogen exposure, genomic instability
- MeSH terms
- APOBEC-1 Deaminase, Carcinogens, Carcinoma, Non-Small-Cell Lung, Cytidine Deaminase, Humans, Lung Neoplasms, Mutation, Neoplasm Recurrence, Local, Prognosis, Smoking, Translocation, Genetic, Tumor Cells, Cultured, Gene Dosage, Genetic Heterogeneity, Evolution, Molecular, Genomic Instability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
